Eternygen's Series A Round

Eternygen raised a round of funding on January 09, 2017.

Eternygen researches and develops drugs for the treatment of nutrition-related metabolic diseases in cooperation with a network of international researchers and research companies. The core competency…

Articles about Eternygen's Series A Round: